Cargando…

Gastrointestinal transcription factors drive lineage-specific developmental programs in organ specification and cancer

Transcription factors (TFs) are spatially and temporally regulated during gut organ specification. Although accumulating evidence shows aberrant reactivation of developmental programs in cancer, little is known about how TFs drive lineage specification in development and cancer. We first defined gas...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Roshane, Guo, Haiyang, Streutker, Catherine, Ahmed, Musaddeque, Yung, Theodora, Dirks, Peter B., He, Housheng Hansen, Kim, Tae-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905862/
https://www.ncbi.nlm.nih.gov/pubmed/31844668
http://dx.doi.org/10.1126/sciadv.aax8898
Descripción
Sumario:Transcription factors (TFs) are spatially and temporally regulated during gut organ specification. Although accumulating evidence shows aberrant reactivation of developmental programs in cancer, little is known about how TFs drive lineage specification in development and cancer. We first defined gastrointestinal tissue–specific chromatin accessibility and gene expression during development, identifying the dynamic epigenetic regulation of SOX family of TFs. We revealed that Sox2 is not only essential for gastric specification, by maintaining chromatin accessibility at forestomach lineage loci, but also sufficient to promote forestomach/esophageal transformation upon Cdx2 deletion. By comparing our gastrointestinal lineage-specific transcriptome to human gastrointestinal cancer data, we found that stomach and intestinal lineage-specific programs are reactivated in Sox2(high)/Sox9(high) and Cdx2(high) cancers, respectively. By analyzing mice deleted for both Sox2 and Sox9, we revealed their potentially redundant roles in both gastric development and cancer, highlighting the importance of developmental lineage programs reactivated by gastrointestinal TFs in cancer.